Pharmacology and Therapeutics

An open label, adaptive, phase 1 trial of high-dose oral nitazoxanide in healthy volunteers: an antiviral candidate for SARS-CoV-2
Lauren E Walker, Richard FitzGerald, Geoffrey Saunders, Rebecca Lyon, Michael Fisher, Karen Martin, Izabela Eberhart, Christie Woods, Sean Ewings, Colin Hale, Rajith KR Rajoli, Laura Else, Sujan Dilly-Penchala, Alieu Amara, David G Lalloo, Michael Jacobs, Henry Pertinez, Parys Hatchard, Robert Waugh, Megan Lawrence, Lucy Johnson, Keira Fines, Helen Reynolds, Timothy Rowland, Rebecca Crook, Kelly Byrne, Pavel Mozgunov, Thomas Jaki, Saye Khoo, Andrew Owen, Gareth Griffiths, Thomas E Fletcher

medRxiv 2021.09.10.21263376; doi: https://doi.org/10.1101/2021.09.10.21263376

Add to Selected Citations
A Learning Health System Randomized Trial of Monoclonal Antibodies for Covid-19
Erin K. McCreary, J. Ryan Bariola, Tami Minnier, Richard J. Wadas, Judith A. Shovel, Debbie Albin, Oscar C. Marroquin, Kevin E. Kip, Kevin Collins, Mark Schmidhofer, Mary Kay Wisniewski, David A Nace, Colleen Sullivan, Meredith Axe, Russell Meyer, Alexandra Weissman, William Garrard, Octavia M. Peck-Palmer, Alan Wells, Robert D. Bart, Anne Yang, Lindsay Berry, Scott Berry, Amy Crawford, Anna McGlothin, Tina Khadem, Kelsey Linstrum, Stephanie K. Montgomery, Daniel Ricketts, Jason N. Kennedy, Caroline J. Pidro, Ghady Haidar, Graham M. Snyder, Bryan J. McVerry, Derek C. Angus, Paula L. Kip, Christopher W. Seymour, David T. Huang

medRxiv 2021.09.03.21262551; doi: https://doi.org/10.1101/2021.09.03.21262551

Add to Selected Citations
Vaccines against Covid-19, venous thromboembolism, and thrombocytopenia. A population-based retrospective cohort study
Joan-Ramon Laporte, Ermengol Coma, Francesc Fina, Luís García-Eroles, Xavier Vidal, Manuel Medina

medRxiv 2021.07.23.21261036; doi: https://doi.org/10.1101/2021.07.23.21261036

Add to Selected Citations
Explant analysis of Utah electrode arrays implanted in human cortex for brain-computer-interfaces
Kevin Woeppel, Christopher Hughes, Angelica J. Herrera, James Eles, Elizabeth C. Tyler-Kabara, Robert A. Gaunt, Jennifer L. Collinger, Xinyan Tracy Cui

medRxiv 2021.08.28.21262765; doi: https://doi.org/10.1101/2021.08.28.21262765

Add to Selected Citations
The efficacy and safety of bamlanivimab treatment against COVID-19: A meta-analysis
Huai-rong Xiang, Bei He, Yun Li, Xuan Cheng, Qi-zhi Zhang, Wen-xing Peng

medRxiv 2021.08.24.21262580; doi: https://doi.org/10.1101/2021.08.24.21262580

Add to Selected Citations
Cardiac Inflammation after COVID-19 mRNA Vaccines: A Global Pharmacovigilance Analysis
Laurent Chouchana, Alice Blet, Mohammad Al-Khalaf, Tahir S. Kafil, Girish Nair, James Robblee, Milou-Daniel Drici, Marie-Blanche Valnet-Rabier, Joëlle Micallef, Francesco Salvo, Jean-Marc Treluyer, Peter P. Liu

medRxiv 2021.08.12.21261955; doi: https://doi.org/10.1101/2021.08.12.21261955

Add to Selected Citations
CandyCodes: Simple universally unique edible identifiers for confirming the authenticity of pharmaceuticals
William H. Grover

medRxiv 2021.07.30.21261395; doi: https://doi.org/10.1101/2021.07.30.21261395

Add to Selected Citations
Doxycycline is a safe alternative to Hydroxychloroquine + Azithromycin to prevent clinical worsening and hospitalization in mild COVID-19 patients: An open label randomized clinical trial (DOXYCOV)
Eugene Sobngwi, Sylvain Zemsi, Magellan Guewo-Fokeng, Jean-Claude Katte, Charles Kounfack, Liliane Mfeukeu-Kuate, Armel Zemsi, Yves Wasnyo, Antoinette Assiga Ntsama, Arnaud Ndi-Manga, Joelle Sobngwi-Tambekou, William Ngatchou, Charlotte Moussi Omgba, Jean Claude Mbanya, Pierre Ongolo Zogo, Pierre Joseph Fouda

medRxiv 2021.07.25.21260838; doi: https://doi.org/10.1101/2021.07.25.21260838

Add to Selected Citations
SGLT2-Inhibition reverts urinary peptide changes associated with severe COVID-19: an in-silico proof-of-principle of proteomics-based drug repurposing
Agnieszka Latosinska, Justyna Siwy, David Z. Cherney, Bruce A. Perkins, Harald Mischak, Joachim Beige

medRxiv 2021.07.21.21260351; doi: https://doi.org/10.1101/2021.07.21.21260351

Add to Selected Citations
Virlaza™ Inhibits Sars-COV-2-induced Inflammatory Response of Bronchial Epithelial Cells and Pulmonary Fibroblast
Maysa Alves Rodrigues Brandao-Rangel, Dobroslav Melamed, Anamei Silva-Reis, Boris Brill, Lucas dos Santos Zamarioli, Carlos Rocha Oliveira, Rodolfo P Vieira

medRxiv 2021.07.17.21260123; doi: https://doi.org/10.1101/2021.07.17.21260123

Add to Selected Citations

Pharmacology and Therapeutics

Pages